Related Experiment Videos
Vinpocetine effects on cognitive impairments produced by flunitrazepam.
1Human Psychopharmacology Research Unit, University of Leeds, U.K.
International Clinical Psychopharmacology
|October 1, 1987
Summary
Vinpocetine, a cognitive enhancer, may improve short-term memory. This study investigated its effects on memory impairment caused by flunitrazepam in healthy volunteers.
Area of Science:
- Neuroscience
- Pharmacology
- Cognitive Psychology
Background:
- Flunitrazepam is known to impair cognitive functions, including memory.
- Vinpocetine is a plant alkaloid used to treat cerebrovascular disorders and some cognitive impairments.
Purpose of the Study:
- To evaluate the efficacy of vinpocetine in mitigating flunitrazepam-induced memory deficits.
- To assess the impact of vinpocetine on various cognitive and subjective measures.
Main Methods:
- A double-blind, placebo-controlled study was conducted.
- Eight healthy volunteers received either vinpocetine (40 mg) or placebo before flunitrazepam administration.
- Cognitive tests included the Critical Flicker Fusion Threshold and Sternberg Memory Scanning Task.
- Subjective drug effects were also recorded.
Main Results:
- Vinpocetine treatment showed modest effects on overall cognitive performance.
- Significant improvements were observed in short-term memory processes following vinpocetine pre-treatment.
- Subjective ratings indicated some modulation of drug action.
Conclusions:
- Vinpocetine may offer benefits for specific aspects of memory, particularly short-term recall.
- Further research is warranted to explore the therapeutic potential of vinpocetine in memory enhancement.
- The findings suggest a potential role for vinpocetine in managing drug-induced cognitive impairment.